Herpes zoster secondary prevention

Herpes zoster Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Herpes zoster from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms Herpes Zoster Congenital Varicella Syndrome
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Herpes zoster secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Herpes zoster secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Herpes zoster secondary prevention
CDC on Herpes zoster secondary prevention
Herpes zoster secondary prevention in the news
Blogs on Herpes zoster secondary prevention
Directions to Hospitals Treating Herpes zoster
Risk calculators and risk factors for Herpes zoster secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; L. Katie Morrison, MD; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]Aysha Anwar, M.B.B.S[3]

Overview

Prompt treatment with antiviral agents (acyclovir, famciclovir and valacyclovir) help reduce the shedding of the virus, decrease the severity and duration of acute pain from zoster and the risk for progression to PHN.

Secondary Prevention

Prompt treatment with antiviral agents (acyclovir, famciclovir and valacyclovir) help reduce the shedding of the virus, decrease the severity and duration of acute pain from zoster and the risk for progression to PHN.